PTPI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Petros Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 0.008 USD -11.11%

Market Cap: $127.1k

	Petros Pharmaceuticals Inc OTC:PTPI	US

Profitability Summary

Petros Pharmaceuticals Inc's profitability score is 13/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

76%

Strong 3Y Average Gross Margin

73%

Gross Margin is Increasing

42% > 76%

Negative Operating Margin

-201%

Negative 3Y Average Operating Margin

-217%

Operating Margin is Increasing

-366% > -201%

Negative Net Margin

-524%

Negative 3Y Average Net Margin

-297%

Net Margin is Increasing

-571% > -524%

Negative Free Cash Flow Margin

-51%

Negative 3Y Average Free Cash Flow Margin

-83%

Free Cash Flow Margin is Increasing

-121% > -51%

Negative ROE

-1 069%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-101%

Declining ROIC

-51% > -88%

View All

Hide

Collapse

13 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.